Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Macy’s, Inc. (M): J.C. Penney Company, Inc. (JCP) Puts Martha Stewart Living Omnimedia, Inc. (MSO) to Bed

Page 1 of 2

It looks like J.C. Penney Company, Inc. (NYSE:JCP) has finally come around to my way of thinking, as I asked the question earlier this year, “Why bother?”

The department store retailer has been locked in a three-way battle between itself, Macy’s, Inc. (NYSE:M), and Martha Stewart Living Omnimedia, Inc. (NYSE:MSO) over use of the domestic diva’s name on products sold in its stores. Earlier this year it won something of a Pyrrhic victory when a judge said it could temporarily sell the items, but couldn’t identify them as coming from Martha Stewart. It was then that I asked, what’s the point? If you can’t gain any of the halo effect associated with the branding that you’re paying for, then it makes no sense to continue fighting — or financing — the war.

J.C. Penney Company, Inc. (NYSE:JCP)

Realizing there was no benefit, J.C. Penney Company, Inc. (NYSE:JCP)’s has finally decided to kick Martha Stewart Living Omnimedia, Inc. (NYSE:MSO) to the curb. The New York Post reports CEO Mike Ullman was unhappy with how sales were going under the $200 million partnership agreement the company signed, and is jettisoning the whole thing.

No kidding. If you’re paying out hard-earned money that you can ill afford to spend right now and are forced to advertise the items as JCP Everyday merchandise instead of Martha Stewart Everyday, shoppers aren’t really going to know they’re getting something endorsed by the diva instead of the regular pots and pans you already sell.

While the paper also reports that Martha Stewart Living Omnimedia, Inc. (NYSE:MSO) issued a statement saying it’s still very much a valued partner with J.C. Penney Company, Inc. (NYSE:JCP), it’s likely the writing is on the wall anyway. The department store chain continues to fight for its financial survival and can’t afford to hemorrhage cash and get no return.

J.C. Penney Company, Inc. (NYSE:JCP) is at a crossroads. Along with the ouster of former CEO Ron Johnson, the retailer just saw the man who put Johnson in place, hedge fund investor Bill Ackman, pull out his entire stake in the company. While two other hedge funds stepped in as a vote of confidence of sorts, the company is really on the precipice.

I’d even go so far as to say it’s not even a company-specific problem, but one endemic to the department store concept generally. While Macy’s, Inc. (NYSE:M)’s received many of the customers who fled J.C. Penney Company, Inc. (NYSE:JCP)’s during the meltdown, as did Kohl’s Corporation (NYSE:KSS), neither one can say it really benefited from its rival’s trials.

For example, while Penney’s continues to suffer from steep declines in sales and comps, they’ve barely budged higher at Kohl’s Corporation (NYSE:KSS)’s. Revenues are up just half a percent, same-store sales are down a like amount, and profits have fallen 4%. Macy’s, Inc. (NYSE:M)’s had a strong first quarter that subsequently took a turn for the worse in the second. It says it anticipates recovery in the back half of the year, but the markets appear doubtful, knocking back its shares 10% from their recent highs.

At least in Penney’s case, while the situation remains horrible, it’s actually less horrible as the months progress — but obviously you can’t sustain a business on a less-bad model. Just as the demise of electronics retailer Circuit City didn’t herald a growth opportunity for Best Buy and Linens ‘n’ Things’ bankruptcy didn’t spur a spate of achievement at Bed Bath & Beyond, Penney’s problems aren’t bolstering the bottom line of its rivals.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!